124 related articles for article (PubMed ID: 34107209)
21. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.
Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C
Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400
[TBL] [Abstract][Full Text] [Related]
22. Neurotensin analogs by fluoroglycosylation at N
Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
[TBL] [Abstract][Full Text] [Related]
23. Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors.
Maschauer S; Prante O
J Labelled Comp Radiopharm; 2018 Mar; 61(3):309-325. PubMed ID: 29114915
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
[TBL] [Abstract][Full Text] [Related]
25. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
[TBL] [Abstract][Full Text] [Related]
26. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
27. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of
Dahlsson Leitao C; Rinne SS; Mitran B; Vorobyeva A; Andersson KG; Tolmachev V; Ståhl S; Löfblom J; Orlova A
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832342
[TBL] [Abstract][Full Text] [Related]
28. Tumor Targeting via Sialic Acid: [
Tsoukalas C; Geninatti-Crich S; Gaitanis A; Tsotakos T; Paravatou-Petsotas M; Aime S; Jiménez-Juárez R; Anagnostopoulos CD; Djanashvili K; Bouziotis P
Mol Imaging Biol; 2018 Oct; 20(5):798-807. PubMed ID: 29464496
[TBL] [Abstract][Full Text] [Related]
29.
Wei X; Liu Z; Zhao Z
Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
[TBL] [Abstract][Full Text] [Related]
30. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
Brand C; Longo VA; Groaning M; Weber WA; Reiner T
Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
[TBL] [Abstract][Full Text] [Related]
31. Increase in negative charge of
Rinne SS; Dahlsson Leitao C; Gentry J; Mitran B; Abouzayed A; Tolmachev V; Ståhl S; Löfblom J; Orlova A
Sci Rep; 2019 Nov; 9(1):17710. PubMed ID: 31776413
[TBL] [Abstract][Full Text] [Related]
32. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
[TBL] [Abstract][Full Text] [Related]
34. Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
Schuhmacher J; Kaul S; Klivényi G; Junkermann H; Magener A; Henze M; Doll J; Haberkorn U; Amelung F; Bastert G
Cancer Res; 2001 May; 61(9):3712-7. PubMed ID: 11325843
[TBL] [Abstract][Full Text] [Related]
35. Novel "bi-modal" H
Ramogida CF; Murphy L; Cawthray JF; Ross JD; Adam MJ; Orvig C
J Inorg Biochem; 2016 Sep; 162():253-262. PubMed ID: 26652124
[TBL] [Abstract][Full Text] [Related]
36. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
[No Abstract] [Full Text] [Related]
37. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
[TBL] [Abstract][Full Text] [Related]
38. In vivo preclinical evaluation of the new
Trencsényi G; Kis A; Szabó JP; Ráti Á; Csige K; Fenyvesi É; Szente L; Malanga M; Méhes G; Emri M; Kertész I; Vecsernyés M; Fenyvesi F; Hajdu I
Int J Pharm; 2020 Feb; 576():118954. PubMed ID: 31935470
[TBL] [Abstract][Full Text] [Related]
39. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform.
Baranyai Z; Reich D; Vágner A; Weineisen M; Tóth I; Wester HJ; Notni J
Dalton Trans; 2015 Jun; 44(24):11137-46. PubMed ID: 25999035
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]